A rare splice donor mutation in the haptoglobin gene associates with blood lipid levels and coronary artery disease

Hum Mol Genet. 2017 Jun 15;26(12):2364-2376. doi: 10.1093/hmg/ddx123.

Abstract

Common sequence variants at the haptoglobin gene (HP) have been associated with blood lipid levels. Through whole-genome sequencing of 8,453 Icelanders, we discovered a splice donor founder mutation in HP (NM_001126102.1:c.190 + 1G > C, minor allele frequency = 0.56%). This mutation occurs on the HP1 allele of the common copy number variant in HP and leads to a loss of function of HP1. It associates with lower levels of haptoglobin (P = 2.1 × 10-54), higher levels of non-high density lipoprotein cholesterol (β = 0.26 mmol/l, P = 2.6 × 10-9) and greater risk of coronary artery disease (odds ratio = 1.30, 95% confidence interval: 1.10-1.54, P = 0.0024). Through haplotype analysis and with RNA sequencing, we provide evidence of a causal relationship between one of the two haptoglobin isoforms, namely Hp1, and lower levels of non-HDL cholesterol. Furthermore, we show that the HP1 allele associates with various other quantitative biological traits.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Base Sequence
  • Coronary Artery Disease / genetics*
  • Coronary Artery Disease / metabolism
  • DNA Copy Number Variations / genetics
  • Female
  • Gene Frequency / genetics
  • Genetic Association Studies / methods
  • Genetic Variation
  • Haptoglobins / genetics*
  • Haptoglobins / metabolism
  • Humans
  • Iceland
  • Lipids / blood
  • Lipids / genetics
  • Lipoproteins / genetics
  • Male
  • Mutation
  • Odds Ratio
  • RNA Splice Sites / genetics
  • Risk Factors

Substances

  • HP protein, human
  • Haptoglobins
  • Lipids
  • Lipoproteins
  • RNA Splice Sites